NCT01411267 2022-04-04
AC220 for Children With Relapsed/Refractory ALL or AML
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1 Completed
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × quizartinib × Other hematologic neoplasm × Clear all